Skip to main content
. Author manuscript; available in PMC: 2014 Jan 18.
Published in final edited form as: N Engl J Med. 2013 Jul 18;369(3):245–254. doi: 10.1056/NEJMoa1301851

Table 3.

Outcomes of Three Rounds of Annual Low-Dose CT Screening, According to Risk Quintile.*

Quintile of 5-Year Risk of Lung-Cancer Death Participants Lung-Cancer Cases Lung-Cancer Deaths Positive Screening Results Number of False Positives per Prevented Lung-Cancer Death Number Needed to Screen
Total No. Stage I Total No. Prevented Total No. False Positive§
no. (%) no. (%) no. (%) no. (%)
All quintiles 26,604 (100) 1083 530 (48.9) 354 88 (24.9) 10,151 9484 (93.4) 108 302
Quintile 1: 0.15–0.55% 5,276 (19.8) 71 40 (56.3) 20 1 (5.0) 1,699 1648 (97.0) 1648 5276
Quintile 2: 0.56–0.84% 5,310 (20.0) 105 59 (56.2) 35 10 (28.6) 1,879 1806 (96.1) 181 531
Quintile 3: 0.85–1.23% 5,396 (20.3) 182 84 (46.2) 45 13 (28.9) 2,024 1911 (94.4) 147 415
Quintile 4: 1.24–2.00% 5,314 (20.0) 263 132 (50.2) 73 31 (42.5) 2,123 1973 (92.9) 64 171
Quintile 5: >2.00% 5,308 (20.0) 462 215 (46.5) 181 33 (18.2) 2,426 2146 (88.5) 65 161
*

The tabulated outcomes include all three rounds of low-dose CT screening and all events that occurred through January 15, 2009.

P<0.05 by means of a linear test of trend in continuous outcomes.

The number needed to screen is the number of participants in the CT group divided by the number of lung-cancer deaths prevented by low-dose CT screening.

§

The number of participants with positive screening results includes all those with any positive result during the trial. P<0.05 by means of the Cochran–Armitage test of trend in proportions.